RxDoctor Payments Data

Sima Jeha

Pediatric Hematology-Oncology · Memphis, TNNPI 1316957921

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $1,250 of the $1,250 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Sanofi-aventis U.S. LLC.

$1,250in general payments, 2019–2025

Across 1 payment — averaging $1250.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi-aventis U.S. LLC$1K
$1,170,402in research payments, 2019–2025

Across 14 payments — averaging $83,600 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$1.2M
  • Amgen$18K

What the payments were for

  • Speaking & faculty fees$1,250100%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Sanofi-aventis U.S. LLC1$1,250

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,250 in reported general payments places this provider in the 55th percentile of 113 pediatric hematology-oncology providers in Tennessee.

See all pediatric hematology-oncology providers in Tennessee

Other pediatric hematology-oncology in Memphis

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →